JNJ
Long Gild - Covid Drug ($MRNA $GSK $INO $SPY $PFE $JNJ $MRK)see full chart at www.tradingview.com
Gild
Entry $62 area
Target 1 $67
Target 2 $71
stoploss $59
Why this play?
Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside.
What is Gild?
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Notable price upgrades
Sep-30-20 Resumed Jefferies Buy $78
Sep-15-20 Upgrade Maxim Group Hold → Buy $88
JNJ - buy support zone (gray) analysisHello traders,
Description of the analysis:
Johnson & Johnson ( JNJ ) support zones ideal for timing long positions (gray). Trade what you understand, trade carefully and sparingly according to the business plan.
About me:
Hi, my name is Jacob Kovarik and I´m trading on stock exchange since 2008. I started with a capital of 3000 USD. My first strategy was based on OTM options. (American stock index and their ETF ). I´ve learnt on my path that professional trading is based on two main fundaments which have to complement each other, to make a bussiness attitude profitable. I´ve tried a lot of techniques and many manners how to analyze the market. From basic technical analysis to fundamental analysis of single title. My analytics gradually changed into professional attitude. I work with logical advantages of stock exchange (return of value back to average, volume , expected volatility , advantage of high stop-loss, the breakdown of time in options, statistics and cosistent thorough control of risk). At the moment, my main target is ITM on SPM index. Biggest part of my current bussiness activity comes from e mini futures (NQ, ES). I´m trader of positions. I´m from Czech republic and I take care of a private fund (over $4.000.000 USD). During my career I´ve earned a lot of valuable experience, such as functionality of strategies and what is more important, control of emotions. Professional trading is, in my opinion, certain kind of mental training and if we are able to control our emotions, accomplishment will show up. I will share with you my analysis and trades on my profile. I wish to all of you successul trades.
Jacob
J&JOHNSON, Flag-Formation Confirmed, Continuation Possible!Hello Traders Investors And Community, welcome to this update-analysis about JOHNSOHN & JOHNSON stock value 4-hour timeframe perspectives where I made an analysis some time ago and therefore we look at the confirmational events happened, the current structure and what to expect next times from this stock. The bull-flag I mentioned in the initial analysis now fully confirmed to the upside and the wave-count ended at the 800-EMA which provided the starting point to break out of the bull-flag and form these nice impulses where the first bull-flag-target will be reached soon at the 155.5 level which is slightly above the all-time-high, as this is an important zone where also supply can enter the market I detected the importance in the current structure we should consider now to anticipate where the journey for this stock is heading.
In my chart, you can watch that the stock is just to complete its second impulse to the upside which is ending at the first bull-flag-target at 155.5 and above the all-time-high-condition, this level is crucial in many places as this can turn out the be a possible bull-trap as supply entering the market, normally what happens when the market approaches such key-levels is minium a correction when not bigger pull-back before backing up and approaching the level again. When the stock shows up with this likely scenario we can expect the pull-back to go to the 100-EMA marked in my chart in green where the stock can stabilize and gain strength in sideways movement before moving up to form a breakout which can confirm the further bullish rising, in this case, it is important that the stock moves above the established all-time-highs with great volatility.
Overall the stock has established some decent and solid bullishness here where it is also trading above the EMAs mentioned important to determine the strongness of stocks in the current mixed market situation, only when the stock crosses below the 100-EMA this can invalidate the bullish scenario, nevertheless, there is a higher possibility given that this support will hold sustainable and new highs will be seen which will activate the middle and long term bull-flag-target. Compared to other stocks and the main market JNJ is in a more bullish situation where many others still trading way below the pre-corona all-time-highs and looking rather weak then strongly bullish, we will see how this situation will develop in this stock-value here, overall the bullishness can go on further after the correction has settled in and the stock gained more strength to form a solid breakout.
In this manner, thank you for watching, support for more market insight, all the best!
"There are many roads to prosperity, but one must be taken."
Information provided is only educational and should not be used to take action in the markets.
Long and hold $GSK ($MRNA $GILD $INO $SPY $PFE $JNJ $MRK)see full chart at www.tradingview.com
GSK
Entry $39.70
Target 1 $42.45
Target 2 $45.50
Target 3 $48
stoploss 38.70
Why this play?
There are 4 general approaches to the Covid vaccine.
1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax)
2.Coronavirus proteins themselves, produced industrially in outside cell cultures,
which will be recognized as foreign matter in the blood. (GlaxoSmithKline/Sanofi, Novavax)
3.A different virus (human or ape adenovirus, measles, etc) that is engineered
to include genetic components coding for the SARS-CoV-2 spike proteins,
which causes the body to then produce them. (CanSino, Oxford, J&J,
Merck/Themis)
4.DNA or RNA that will be taken up by cells and will cause them to make
coronavirus proteins. (Moderna, Innovio,
BioNTech/Pfizer)
GSK is #2, there is only 1 other big company doing this approach and that is NVAX.
We are betting on the fact that if they are successful, they could have super run like NVAX.
What is GSk?
www.gsk.com
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Johnson & Johnson Will FallJNJ has, like many of the individual stocks I have recently covered, also formed a long-term rising broadening pattern. But whereas with, say, Amazon, which is at the top of its broadening pattern's range, Johnson & Johnson looks to have completed that last stop in January of 2018.
After the final touch on the bottom, in this case March of this year, the price action generally follows the arc.
PT still 157 JNJ is next. Entered this at .59. Down 8$. Should have a nice run up during the week for running. The good thing is that the call is for 7/24 so theta won't crush us. PT is 157. Closed above the resistance and looks like it's ready to break out of its down trend. Will sell for profit Wednesday. Don’t want to hold through earnings.
JNJ 157 PTJNJ has earnings this week. Resistance is at 144.65. Going to watch it break. Broke out of its channel. It's moving sideways, so going to need the Monday candle to determine where we are going. Will most likely buy the 150 call for July 24th to give me a some time for movement as well as keep theta from smacking me. Play smart please
JNJ Long Set-upJNJ
ENTRY = 618 Reaction @ 138 or a break above and a hodl of the 200ema on Daily @ 142
1st Target = 786@ 146
HODL Target = 157+
________________________________________________
This content is for informational and educational purposes only. This is not in any way, shape or form financial or trading advice.
Good luck, happy trading and stay chill,
2degreez
MARKET OVERVIEW 👨👩👧👦 | $SPY + $APPL + $JNJ + $JPM + $T📊📊📊Let's take a look at the S&P, Apple, Johnson and Johnson, and AT&T. Today we are looking to see if we can find the direction of the market going into the week by analyzing some top S&P holdings that are indicative of different key sectors.
The idea is to look at two bullish sector charts Apple (tech) and Johnson and Johnson (healthcare), and two bearish charts JP. Morgan (financials) and AT&T (communications), to see if we can find the direction of the market.
While our money is on more upside eventually (especially with Apple making an All-Time High (ATH), zero interest rates, and stimulus outweighing temporary slow recovery concerns), we want to know if the bears of the market pull us down or the bulls can sustain continued uptrend going into the week.
This write up took a long time so please Hit that 👍 button to show support for the content and help us grow 🐣
---
S&P 500 Index
Support S&P:
We have found a reaction on the S1 major price pivot point at the S/R flip. This is of course the ideal spot for the bulls to find support. If that last wick was the only test of this level we end up getting, all the better for the bulls.
If we do need to test lower levels, then the S2 untested bullish orderblock right below us provides another chance at retaining a bullish market structure.
If neither of these hold, the bulls have one last chance at the uptrend with the S3 orderblock cluster and previous range lows. A grind down to this level like we see with AT&T seems like one possible pathway there.
Resistance S&P:
The main resistance we will be looking at with most of these charts is seen in the S&P's R1 orderblock cluster at the previous swing high.
Regardless of where we find support, this resistance will be the main point of contention.
---
Apple
Support APPL:
Apple is by far the most bullish asset here. It is also the top holding of the S&P. The major support for Apple is the S1 orderblock and S/R flip cluster at the previous All-Time High. For the rest of the market to retain a bullish structure, S1 holding is key.
If S1 can't hold, the S2 orderblock and gap-fill is the next best hope for the bulls. The bulls don't want to see any weakness for Apple, so holding these levels and making new highs is key.
Resistance APPL:
Apple resembles the S&P, and that is logical because it is the biggest S&P holding. Rejection at R1 for Apple means no new ATH. Breaking R1 means a new ATH. How Apple reacts matters for the market. We see this one being broken eventually, but it has to happen sooner rather than later to lift the rest of the market up and avoid a "slow recovery."
---
Johnson & Johnson
Support JNJ:
The S1 orderblock and gap-fill on JNJ is about to be tested and is the ideal support. Finding support here means another point for the S&P bulls because we get JNJ working for us and not against us.
If S1 can't hold, we have S2 not too far away, this plays into the S&P's S2 holding as well. A dip this low isn't ideal, but the bullish market structure isn't broken if S2 holds.
Resistance JNJ:
JNJ has been correcting longer than most of the stocks on this chart. Of course, it also has a more bullish overall structure than our JPM and T bearish charts. For JNJ though, the longer correction means more levels of resistance, both the R1 S/R and orderblock and R2 S/R stand in the way for JNJ. This makes it a little harder to rely on than Apple from a pure TA perspective.
---
J.P. Morgan
Support JPM:
Big banks have their pros and cons right now, but for the market to reflect those pros S1 holding is ideal. JPM could be off to the races, or it could be making a drawn-out bottom formation.
A retest of S2 gives weight to that long drawn out bottom, therefore the big bank and S&P bulls want S1 to hold so we can maintain momentum.
Resistance JPM:
The primary resistance for J.P. Morgan is the R1 orderblock at the prior swing high. The recent market structure is similar to Apple and the S&P as a whole, it is only the previous structure that signals that JPM is a weaker asset currently. Some good JPM fundamentals could help the S&P here.
---
AT&T
Support T:
AT&T is the most bearish S&P holding we are charting. It lost its major support and is onto the S2 S/R and orderblock cluster. If this one doesn't hold, giving us a higher low, then we are simply retesting the COVID lows. If major holdings start breaking down to new lows, its a bad look for the market. The best way to avoid making new lows is not to retest old lows and instead to make lower highs. This is what the bulls want from T.
Resistance T:
Even though this is the most bearish chart, there isn't a ton of noteworthy resistance, which is a good thing. R1 is the main resistance for T. This range is notable as it was a previous resistance as well, T has this in common with the S&P... which helps confirm R1 being an important level to breach for the bulls.
---
Summary:
The S&P rallying from here or consolidating above S1 would be ideal for the bulls. For this, we need the more bullish S&P holdings like APPL and JNJ to hold their respective support levels and then rally while weaker holdings like JPM and AT&T avoid too much further correction.
If some of the weaker holdings can find support at their current ranges, or perhaps even at the next range down while the more bullish holdings stay their ground, then we could still be looking for S1 and S2 to hold for the S&P.
However, if the market tries to go bear, then we would more be looking big tech like Apple to hold up the rest of the market like Atlas while we eye S3 for support for the S&P.
It seems unlikely that we make new lows, and so we are looking for support to hold overall, but a trip down to S3 certainly will have an overall market recovery mimicking the slower recovery noted by the FED and this scenario likely results in retests of the bottom for some of the weaker S&P holdings.
Will the S&P pull an Apple and aim for new All-Time Highs, will it correct for a bit like JNJ perhaps taking us to S3, or are we going to get a JPM and T style upset? That is the question.
Resources:
www.zacks.com + www.nytimes.com
The Baby Powder Gives You Cancer! 😯 (JNJ)📈 Failed to breach through the highs, but the fight ain't over yet!
Downward channel identified. Seeing a lot of rejection at this channel top as we approach a critical level of support at 143.47.
You want to long when the downward black Resistance gets cracked. Otherwise short 143.47 break and see if the bottom channel support holds.
Critical to use the ema dots and the Crossover strategy at that 143.47 level for a more aggressive long if held.
Could be double top or could be cup and handle. 🤷♂️
Play the channel.
Best of luck! 🎲
🥇MLT | MAJOR LEAGUE TRADER